Evidence map›Paper›PMID 42191985›Full record

ArticleBone marrow transplantation2026

The 2026 definition of ruxolitinib refractoriness in severe acute GVHD.

Florent Malard, Yi Bin Chen, Monzr M Al Malki, Miguel-Angel Perales, Zinaida Peric, Annalisa Ruggeri, Eolia Brissot, Jaime Sanz, Rafael Duarte, Linde Morsink and 7 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Florent MalardCentre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, Paris, France. florent.malard@inserm.fr.ORCID http://orcid.org/0000-0002-3474-0002
Yi Bin ChenHematopoietic Cell Transplant & Cell Therapy Program, Massachusetts General Brigham Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9554-1058
Monzr M Al MalkiDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0001-8226-471X
Miguel-Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5910-4571
Zinaida PericDepartment of Hematology, University Hospital Centre Rijeka, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Annalisa RuggeriIRCCS San Raffaele Scientific Institute, Milano, Italy.ORCID http://orcid.org/0000-0002-7261-2765
Eolia BrissotCentre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, Paris, France.ORCID http://orcid.org/0000-0003-4471-418X
Jaime SanzHematology, University Hospital La Fe, Madrid, Spain.ORCID http://orcid.org/0000-0001-6934-4619
Rafael DuarteDepartment of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Linde MorsinkUniversity Medical Center Groningen, Groningen, The Netherlands.
Alexandros SpyridonnidisUniversity of Patras, Institute of Cell Therapy, Patras, Greece.ORCID http://orcid.org/0000-0003-3097-2532
Giorgia BattipagliaHematology Department, Federico II University of Naples, Naples, Italy.ORCID http://orcid.org/0000-0002-0695-3879
Ryotaro NakamuraDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0002-9082-0680
Mohamed Kharfan-DabajaDivision of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0001-7394-5185
Olaf PenakCharité - University Medicine Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-4876-802X
Robert ZeiserDepartment of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Freiburg University Medical Center, Freiburg im Breisgau, Germany.ORCID http://orcid.org/0000-0001-6565-3393
Mohamad MohtyCentre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, Paris, France. mohamad.mohty@inserm.fr.ORCID http://orcid.org/0000-0002-7264-808X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42191985

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.